Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kythera Biopharmaceuticals
Biotech
Sienna slumps as acne asset flunks phase 3 trials
The addition of the silver particle treatment to laser light therapy failed to improve outcomes against three key endpoints in two trials.
Nick Paul Taylor
Jul 30, 2018 9:21am
JLABS alumnus Sienna guns for $75M IPO months after series B
Jul 6, 2017 4:25am
Ex-Kythera team raises $40M for dermatology clinical trials
Apr 25, 2017 5:04am
Kythera vets regroup around a $34M cosmetic biotech startup
Apr 29, 2016 9:54am